Takeda Pharmaceutical (TAK) Change in Acquisitions & Divestments (2018 - 2026)
Takeda Pharmaceutical (TAK) reported Change in Acquisitions & Divestments of $2.35 million for the quarter ended Jun 30, 2026, down 69.8% from $7.8 million a year earlier and down 66.5% from the prior quarter.
Takeda Pharmaceutical (TAK) Change in Acquisitions & Divestments (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Takeda Pharmaceutical's Change in Acquisitions & Divestments came in at $200.71 million, down 18.1% year-over-year; for the year ended Mar 31, 2026, it came in at $46.71 million, down 75.8% from the prior year.
- Change in Acquisitions & Divestments has a five-year compound annual growth rate of -41.9% (years ended Mar 2021 to Mar 2026).
- By year, Change in Acquisitions & Divestments came in at $193.28 million in the year ended Mar 31, 2025 (+247.5%), $55.62 million in the year ended Mar 31, 2024 (-66.2%), $164.73 million in the year ended Mar 31, 2023 (+9.3%) and $150.72 million in the year ended Mar 31, 2022 (-78.6%).
- The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly Change in Acquisitions & Divestments since the quarter ended Sep 30, 2019.
- Year over year, Change in Acquisitions & Divestments has now declined in each of the last three quarters, with growth averaging 49.6% over the last eight quarters.
- The high point for year-over-year Change in Acquisitions & Divestments in five years was the quarter ended Jun 30, 2024 (growth of 762.0%); the low point was the quarter ended Jun 30, 2023 (a decline of 91.7%).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $7.01 million (quarter ended Mar 31, 2026), $10.14 million (quarter ended Dec 31, 2025) and $181.21 million (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Takeda Pharmaceutical | 2.58 Bn | -23.92 Bn | 5.10 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.35 Mn |
| Mar 31, 2026 | 7.01 Mn |
| Dec 31, 2025 | 10.14 Mn |
| Sep 30, 2025 | 181.21 Mn |
| Jun 30, 2025 | 7.80 Mn |
| Mar 31, 2025 | 34.74 Mn |
| Dec 31, 2024 | 23.44 Mn |
| Sep 30, 2024 | 179.00 Mn |
| Jun 30, 2024 | 34.16 Mn |
| Mar 31, 2024 | 35.76 Mn |
| Dec 31, 2023 | 3.10 Mn |
| Sep 30, 2023 | 142.64 Mn |
| Jun 30, 2023 | 3.96 Mn |
| Mar 31, 2023 | 46.87 Mn |
| Dec 31, 2022 | 15.24 Mn |
| Sep 30, 2022 | 149.16 Mn |
| Jun 30, 2022 | 47.77 Mn |
| Jun 30, 2021 | 4.41 Mn |
| Mar 31, 2021 | 8.38 Mn |
| Jun 30, 2020 | 413.18 Mn |
Takeda Pharmaceutical Change in Acquisitions & Divestments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-acquisitions-and-divestments&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-acquisitions-and-divestments", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-acquisitions-and-divestments&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();